A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response.
Granulocyte colony-stimulating factor
Hepatocellular carcinoma
Leukocytosis
Journal
Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
27
05
2020
accepted:
13
09
2020
pubmed:
18
10
2020
medline:
29
6
2021
entrez:
17
10
2020
Statut:
ppublish
Résumé
The granulocyte colony-stimulating factor (G-CSF) is a glycoprotein that stimulates cell proliferation and differentiation of precursor cells in the bone marrow. Several cases of G-CSF-producing malignant tumors in various organs have been reported, but there are only nine cases of G-CSF-producing hepatocellular carcinoma (HCC) reported in the English literature. G-CSF-producing tumors grow rapidly and have a high probability of distant metastases; thus, they generally have a poor prognosis. Given that the mechanism of the carcinogenesis of G-CSF-producing HCC remains unclear, an efficient treatment strategy also remains to be elucidated. We report herein a case of G-CSF-producing HCC accompanied by leukocytosis and high serum G-CSF concentrations in the disease progression stage after long-term complete response. We also reviewed previous reports to investigate the clinical behaviors of G-CSF-producing HCC, including our case. Clinicians should consider G-CSF-producing HCC in patients with a hepatic mass and drastic leukocytosis, without any evidence of infection and blood disorders. Early diagnosis and prompt therapy, including radical resection, may provide a more favorable prognosis.
Identifiants
pubmed: 33068269
doi: 10.1007/s12328-020-01239-9
pii: 10.1007/s12328-020-01239-9
doi:
Substances chimiques
Granulocyte Colony-Stimulating Factor
143011-72-7
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
204-211Références
Robinson WA. Granulocytosis in neoplasia. Ann N Y Acad Sci. 1974;230:212–8.
doi: 10.1111/j.1749-6632.1974.tb14451.x
Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med. 1992;327:28–35.
doi: 10.1056/NEJM199207023270106
Asano S, Urabe A, Okabe T, et al. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood. 1977;49:845–52.
doi: 10.1182/blood.V49.5.845.845
Shijubo N, Inoue Y, Hirasawa M, et al. Granulocyte colony-stimulating factor-producing large cell undifferentiated carcinoma of the lung. Intern Med. 1992;31:277–80.
doi: 10.2169/internalmedicine.31.277
Tachibana M, Miyakawa A, Tazaki H, et al. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res. 1995;55:3438–43.
pubmed: 7542171
Ikeda T, Ohgaki K, Miura M, et al. Granulocyte-colony stimulating factor-producing gallbladder cancer without recurrence more than 2 years after resection: report of a case. Surg Today. 2005;35:590–3.
doi: 10.1007/s00595-004-2981-4
Nakajima A, Takahashi H, Inamori M, et al. Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report. J Med Case Rep. 2008;2:391.
doi: 10.1186/1752-1947-2-391
Iwasa K, Noguchi M, Mori K, et al. Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case. Surg Today. 1995;25:158–60.
doi: 10.1007/BF00311090
Kyo S, Kanaya T, Takakura M, et al. A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6. Gynecol Oncol. 2000;78:383–7.
doi: 10.1006/gyno.2000.5904
Nagamatsu H, Hiraki M, Mizukami N, et al. Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis. Aliment Pharmacol Ther. 2010;32:543–50.
doi: 10.1111/j.1365-2036.2010.04379.x
Yamamoto S, Takashima S, Ogawa H, et al. Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma. J Gastroenterol. 1999;34:640–4.
doi: 10.1007/s005350050387
Amano H, Itamoto T, Emoto K, et al. Granulocyte colony-stimulating factor-producing combined hepatocellular/cholangiocellular carcinoma with sarcomatous change. J Gastroenterol. 2005;40:1158–9.
doi: 10.1007/s00535-005-1715-8
Araki K, Kishihara F, Takahashi K, et al. Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int. 2007;27:716–21.
doi: 10.1111/j.1478-3231.2007.01468.x
Joshita S, Nakazawa K, Koike S, et al. A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry. J Korean Med Sci. 2010;25:476–80.
doi: 10.3346/jkms.2010.25.3.476
Kohno M, Shirabe K, Mano Y, et al. Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case. Surg Today. 2013;43:439–45.
doi: 10.1007/s00595-012-0202-0
Snyder RA, Liu E, Merchant NB. Granulocyte colony stimulating factor secreting hepatocellular carcinoma. Am Surg. 2012;78:821–2.
doi: 10.1177/000313481207800727
Ito T, Okubo K, Shiomi M, et al. A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur-uracil. Nihon Shokakibyo Gakkai Zasshi. 2012;109:2088–96.
pubmed: 23221058
Nagata H, Komatsu S, Takaki W, et al. Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes. World J Clin Oncol. 2016;7:380–6.
doi: 10.5306/wjco.v7.i5.380
Sakamoto Y, Kamiyama T, Yokoo H, et al. Hepatocellular carcinoma producing granulocyte colony-stimulating factor: diagnosis and treatment. Int Cancer Conf J. 2019;8:12–6.
doi: 10.1007/s13691-018-0346-x
Wang SY, Chen LY, Tsai TF, et al. Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation. Exp Hematol. 1996;24:437–44.
pubmed: 8599973
Kojiro M, Sugihara S, Kakizoe S, et al. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol. 1989;23:S4-8.
doi: 10.1007/BF00647229
Baba M, Hasegawa H, Nakayabu M, et al. Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF. Am J Hematol. 1995;49:207–15.
doi: 10.1002/ajh.2830490306
Jana S, Patel H. Expression of human granulocyte colony stimulating factor (hG-CSF) in colon adenocarcinoma cell line (Caco-2). Biotechnol Lett. 2012;34:1791–6.
doi: 10.1007/s10529-012-0977-5
Suzuki A, Takahashi T, Okuno Y, et al. Liver damage in patients with colony-stimulating factor-producing tumors. Am J Med. 1993;94:125–32.
doi: 10.1016/0002-9343(93)90173-M
Narsale AA, Carson JA. Role of interleukin-6 in cachexia: therapeutic implications. Curr Opin Support Palliat Care. 2014;8:321–7.
doi: 10.1097/SPC.0000000000000091